Table 3. Multivariate analysis of clinical characteristics associated with local progression-free survival (LPFS), relapse-free survival (RFS), and overall survival (OS).
| Characteristics | LPFS | RFS | OS | ||||
|---|---|---|---|---|---|---|---|
| Hazard Ratio (95% CI) | p-value† | Hazard Ratio (95% CI) | p-value† | Hazard Ratio (95% CI) | p-value† | ||
| Child-Pugh Classification | A | - | - | - | - | 1.000 | 0.017 |
| B | - | - | 6.992 (1.423–34.340) | ||||
| AJCC stage | I–II | - | - | - | - | 1.000 | 0.005 |
| IIIA | - | - | 7.059 (1.788–27.870) | ||||
| Tumour response | CR | 1.000 | <0.001 | 1.000 | 0.027 | 1.000 | <0.001 |
| Non-CR | 115.149 (12.300–1077.953) | 3.392 (1.148–10.026) | 15.801 (4.886–51.103) | ||||